Wontec's stock is showing strong performance after signing a sales contract for the universal electrosurgical device 'OligioX' with a Brazilian medical device distribution company.
As of 9:34 AM on the 19th, Wontec was trading at 7,310 KRW, up 580 KRW (8.62%) from the previous trading day.
The day before, Wontec announced that it had signed a sales contract for OligioX with 'Skintec' in Brazil. Wontec plans to promote marketing and sales activities for OligioX in Brazil.
On the same day, Shin Minsu, a researcher at Kiwoom Securities, said, "Although the second-quarter performance this year is expected to fall short of market expectations with sales of 30.4 billion KRW and operating profit of 10.5 billion KRW, overseas export data centered on Thailand recorded the highest monthly figures ever."
He added, "In the third quarter, several stock price growth drivers are expected to emerge, including large-scale overseas orders for Oligio consumable tips, obtaining Brazilian approval for OligioX along with shipments of MOQ (minimum order quantity) volumes, full-scale partnership activities in Brazil, and recognition of delayed sales revenue for Thailand, potentially creating a turning point."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![[Featured Stock] Wontec Surges Over 8% as 'Brazil Partnership Kicks Off'](https://cphoto.asiae.co.kr/listimglink/1/2023052309414939672_1684802510.jpg)

